ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+8.45%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$17.4M
AUM Growth
-$93.9M
(-84%)
Cap. Flow
-$98.8M
Cap. Flow
% of AUM
-566.33%
Top 10 Holdings %
Top 10 Hldgs %
70.1%
Holding
52
New
9
Increased
–
Reduced
16
Closed
27
Top Buys
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$1.55M |
| 2 |
Icon
ICLR
|
$1.04M |
| 3 |
Labcorp
LH
|
$906K |
| 4 |
Encompass Health
EHC
|
$859K |
| 5 |
Pfizer
PFE
|
$455K |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$16.9M |
| 2 |
Bruker
BRKR
|
$6.93M |
| 3 |
AstraZeneca
AZN
|
$6.53M |
| 4 |
Thermo Fisher Scientific
TMO
|
$5.34M |
| 5 |
Elevance Health
ELV
|
$5.13M |
Sector Composition
| 1 | Healthcare | 98.36% |
| 2 | Real Estate | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
GoodRx Holdings
GDRX
$1.49B
| – | – |
-87,290
| Closed | -$491K |
|
27
Abbott
ABT
$231B
| – | – |
-18,040
| Closed | -$1.75M |
|
28
Arcellx
ACLX
$4B
| – | – |
-14,158
| Closed | -$508K |
|
|
ADAP
29
Adaptimmune Therapeutics
ADAP
$13.4M
| – | – |
-311,944
| Closed | -$243K |
|
30
AdaptHealth
AHCO
$1.24B
| – | – |
-89,937
| Closed | -$818K |
|
31
argenx
ARGX
$44.9B
| – | – |
-9,108
| Closed | -$4.48M |
|
32
Axsome Therapeutics
AXSM
$6.21B
| – | – |
-11,254
| Closed | -$787K |
|
|
33
AstraZeneca
AZN
$254B
| – | – |
-96,444
| Closed | -$6.53M |
|
34
Azenta
AZTA
$1.35B
| – | – |
-19,422
| Closed | -$975K |
|
|
BLUE
35
DELISTED
bluebird bio
BLUE
| – | – |
-12,589
| Closed | -$765K |
|
|
36
Bruker
BRKR
$4.51B
| – | – |
-111,276
| Closed | -$6.93M |
|
37
CONMED
CNMD
$1.69B
| – | – |
-41,984
| Closed | -$4.23M |
|
38
DexCom
DXCM
$31.7B
| – | – |
-20,694
| Closed | -$1.93M |
|
39
89bio
ETNB
$1.27B
| – | – |
-82,153
| Closed | -$1.27M |
|
40
Insmed
INSM
$30.1B
| – | – |
-79,471
| Closed | -$2.01M |
|
41
IQVIA
IQV
$31.4B
| – | – |
-3,946
| Closed | -$776K |
|
42
Merck
MRK
$210B
| – | – |
-44,384
| Closed | -$4.57M |
|
43
Envista
NVST
$3.45B
| – | – |
-10,787
| Closed | -$301K |
|
44
Ocular Therapeutix
OCUL
$2.21B
| – | – |
-353,707
| Closed | -$1.11M |
|
45
Omega Healthcare
OHI
$12.6B
| – | – |
-80,070
| Closed | -$2.66M |
|
46
Olema Pharmaceuticals
OLMA
$434M
| – | – |
-58,573
| Closed | -$723K |
|
47
Cartesian Therapeutics
RNAC
$262M
| – | – |
-15,110
| Closed | -$481K |
|
48
Stryker
SYK
$151B
| – | – |
-7,547
| Closed | -$2.06M |
|
49
Tarsus Pharmaceuticals
TARS
$2.42B
| – | – |
-47,649
| Closed | -$847K |
|
50
iShares 20+ Year Treasury Bond ETF
TLT
$48.1B
| – | – |
-3,400
| Closed | -$302K |
|